Andersen SR - Search Results

1

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

Haneberg B, Dalseg R, Wedege E, Høiby EA, Haugen IL, Oftung F, Andersen SR, Naess LM, Aase A, Michaelsen TE, Holst J. Haneberg B, et al. Among authors: andersen sr. Infect Immun. 1998 Apr;66(4):1334-41. doi: 10.1128/IAI.66.4.1334-1341.1998. Infect Immun. 1998. PMID: 9529050 Free PMC article.

2

Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response.

Andersen SR, Bjune G, Høiby EA, Michaelsen TE, Aase A, Rye U, Jantzen E. Andersen SR, et al. Vaccine. 1997 Aug;15(11):1225-34. doi: 10.1016/s0264-410x(97)00030-3. Vaccine. 1997. PMID: 9286048

3

Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.

Haneberg B, Dalseg R, Oftung F, Wedege E, Høiby EA, Haugen IL, Holst J, Andersen SR, Aase A, Meyer Naess L, Michaelsen TE, Namork E, Haaheim LR. Haneberg B, et al. Among authors: andersen sr. Dev Biol Stand. 1998;92:127-33. Dev Biol Stand. 1998. PMID: 9554266 Clinical Trial.

4

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine.

Berstad AK, Andersen SR, Dalseg R, Dromtorp S, Holst J, Namork E, Wedege E, Haneberg B. Berstad AK, et al. Among authors: andersen sr. Vaccine. 2000 Mar 17;18(18):1910-9. doi: 10.1016/s0264-410x(99)00442-9. Vaccine. 2000. PMID: 10699340

5

A mouse model utilising human transferrin to study protection against Neisseria meningitidis serogroup B induced by outer membrane vesicle vaccination.

Oftung F, Lovik M, Andersen SR, Froholm LO, Bjune G. Oftung F, et al. Among authors: andersen sr. FEMS Immunol Med Microbiol. 1999 Oct;26(1):75-82. doi: 10.1111/j.1574-695X.1999.tb01374.x. FEMS Immunol Med Microbiol. 1999. PMID: 10518045 Free article.

6

Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines.

Andersen SR, Bjune G, Lyngby J, Bryn K, Jantzen E. Andersen SR, et al. Microb Pathog. 1995 Sep;19(3):159-68. doi: 10.1006/mpat.1995.0054. Microb Pathog. 1995. PMID: 8559044

7

Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle.

Tollersrud T, Zernichow L, Andersen SR, Kenny K, Lund A. Tollersrud T, et al. Among authors: andersen sr. Vaccine. 2001 Jul 16;19(28-29):3896-903. doi: 10.1016/s0264-410x(01)00124-4. Vaccine. 2001. PMID: 11427263

8

Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants.

Tollersrud T, Nørstebø PE, Engvik JP, Andersen SR, Reitan LJ, Lund A. Tollersrud T, et al. Among authors: andersen sr. Vet Res Commun. 2002 Dec;26(8):587-600. doi: 10.1023/a:1020960402112. Vet Res Commun. 2002. PMID: 12507034 Clinical Trial.

9

Drug addict rehabilitation: a burden on society?

Berg JE, Andersen S. Berg JE, et al. Int J Rehabil Res. 1992;15(4):301-9. Int J Rehabil Res. 1992. PMID: 1336768 No abstract available.

10

Street sale of heroin--a profitable way of making a living?

Berg JE, Andersen S. Berg JE, et al. Drug Alcohol Depend. 1993 May;32(3):287-91. doi: 10.1016/0376-8716(93)90094-7. Drug Alcohol Depend. 1993. PMID: 8348878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters